Skip to search formSkip to main contentSkip to account menu

NC100150

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2015
Highly Cited
2015
  • Yixiang Wang
  • World journal of gastroenterology
  • 2015
  • Corpus ID: 31333106
Five types of superparamagnetic iron oxide (SPIO), i.e. Ferumoxides (Feridex(®) IV, Berlex Laboratories), Ferucarbotran (Resovist… 
Highly Cited
2004
Highly Cited
2004
The purpose of this study was to determine the cellular distribution and degradation in rat liver following intravenous injection… 
2004
2004
To investigate the duration of liver R2* enhancement and pharmacokinetics following administration of an iron oxide nanoparticle… 
Highly Cited
2003
Highly Cited
2003
To investigate the physiological origins responsible for the varying blood oxygenation level dependent (BOLD) magnetic resonance… 
Highly Cited
2001
Highly Cited
2001
PURPOSE To define the diagnostic potential of magnetic resonance (MR) imaging enhanced with ultrasmall superparamagnetic iron… 
Highly Cited
2000
Highly Cited
2000
A preparation of monocrystalline iron oxide nanoparticles with an oxidized starch coating, currently in clinical trials (NC100150… 
Highly Cited
1999
Highly Cited
1999
In this Phase I clinical study, a novel ultrasmall superparamagnetic iron oxide contrast agent, NC100150 Injection (Nycomed… 
1999
1999
Recent developments of novel magnetic resonance intravascular contrast agents with low T1 in blood and a long intravascular half… 
1999
1999
A new ultrasmall superparamagnetic iron oxide (Clariscan; NC100150 Injection) was studied in domestic farm pigs. The T1 effects…